Background: HCV is a contagious blood-borne virus that attacks the liver and can be deadly despite often having no visible health warnings. IL-18 is an important proinflammatory cytokine secreted from Kupffer cells. It is involved in the pathogenesis of HCV infection through modulating immune functions by regulating IFN-γ production and promoting the development of Th1 immune responses. Objective: The aim of this study is to measure serum level of Il-18 in chronic hepatitis C patients and compare between Il-18 levels and the degree of liver fibrosis.
INTRODUCTION
epatitis C is a serious disease that is widely distributed in most parts of the world especially in Egypt [1] . It was formerly identified as a putative viral hepatitis occurring after transfusion of blood products or intravenous drug use. There was evidence that hepatitis C could lead to persistent infection in a high proportion of infected individuals, and could progress to chronic liver disease, cirrhosis and hepatocellular carcinoma (HCC) [2] .
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January 2019 Volume 25 Issue 1 www.zumj.journals.ekb.eg -72-Approximately 30% of patients with chronic HCV infection have persistently normal ALT levels. the majority of these patients have some degree of histological liver damage that may be significant in up to 20% of cases and might progress towards a more severe degree of liver fibrosis [3] . The assessment of disease progression not only provides useful information for diagnosis and therapeutic supervision judgment but also for monitoring disease [4] . persistent exposure of kupffer cells to HCV will continuously activate kupffer cells leading to the ongoing release of cytokines like IL-18 attracting and activating more leukocytes. Likewise, continuous activation of infiltrating leukocytes leads to ongoing production of IL-18 that indirectly activate kupffer cells [5] . Proinflammatory cytokines play a dual role in virus infection. In acute infection, these cytokines act as an antiviral and help to clear infection. On the other hand, these cytokines may stimulate inflammatory processes in chronic infection. Therefore, HCV-mediated activation of IL-18 from macrophages may activate quiescent hepatic stellate cells toward fibrosis and may be a potential target for therapeutic modalities [6] . The aim of this study is to measure serum level of Il-18 in chronic hepatitis C patients and compare between Il-18 levels and the degree of liver fibrosis in hepatitis C viral infection.
SUBJECTS AND METHODS This is a case control study. It was conducted in Clinical Pathology and Tropical Medicine Departments, Faculty of Medicine, Zagazig University Hospitals during the period from June 2017 to August 2017. Formal consent was obtained from all individual and the study protocol was approved by the Zagazig medical research ethical committee.
Eighty four subjects were included in this study; they were classified into three groups as follows:
Group 1: composed of 28 (17 males,11 females) apparently healthy subjects their ages ranged from 27 to 61 years old . There were no statistical significant differences between the three studied groups in age or sex distribution (p value >0.05). -75-This table shows that there were high statistical significant differences between the three studied groups in IL-18. Using LSD to find difference between groups showed that the difference was between Group III compared to both Group I and Group II. -76-HCV infection is a major health problem in Egypt as the nation bears the highest prevalence rate worldwide [7] . Chronic infection with HCV is the leading cause of end stage liver disease, HCC and liver-related death in the country [8] . liver function tests are insensitive for predicting disease progression. Serum ALT may be elevated in patients without significant histological abnormality. Similarly, normal values do not exclude progressive liver disease or cirrhosis [9] . Different invasive and non-invasive methods are applied to diagnose the disease from initial to end stage [10] . Percutaneous liver biopsy has been considered the golden standard for the histological assessment of liver fibrosis [11] . However, liver biopsy has several limitations. The procedure is invasive and painful, with the risk of rare but potential life-threatening complications [12] FibroScan is a non-invasive test that assesses stiffness in the liver [13] . Its results had good correlation with the histology of liver fibrosis in patients with hepatitis C [14] . However, measurements can be difficult to obtain in obese patients or in those who have narrow intercostal spaces, and is impossible to achieve in patients with ascites [15] . Once hepatocytes are productively infected with HCV, cellular defenses become activated. Hepatocytes trigger kupffer cells to produce cytokines such as IL-18 to recruit IFN-γ producing NK cells to the liver [16] . IL-18 is a proinflammatory cytokine with immunomodulatory functions by enhancing T cell responses, regulating IFN-γ production and promoting the development of Th1 immune responses [17] . Hepatic inflammatory activity in chronic hepatitis C was shown to be closely associated with an increased amount of IL-18 [18] . The present study was carried on 84 subjects classified into 3 groups: Group I included 28 healthy subjects, 17 were males(60.7%) and 11 were females(39.3%), their ages ranged from 27 to 61 years with mean ages 45.39 ± 9.31, Group II included 28 patients with chronic hepatitis C with normal liver enzymes, 15 were males(53.6%) and 13 were females(46.4%), their ages ranged from 25 to 63 years with mean ages 42.75 ± 11.62 and Group III included 28 patients with chronic hepatitis C with elevated liver enzymes, 16 were males(57.1%) and 12 were females(42.9%), their ages ranged from 29 to 64 years with mean ages 43.64 ± 10.23 with no statistical significant differences between the three studied groups in age or sex distribution (p value >0.05).
The present study showed high statistical significant differences between the three studied groups as regard serum ALT (K=61.01) and AST (K=55.47). The difference was between Group III compared to both group I and II (p value<0.01) but no difference was found between Group I and Group II (p value >0.05). Increases of serum AST activity generally parallel those of ALT and are therefore considered to be a sensitive marker for hepatocellular injury [19] . However, Wedemeyer et al., found that the cause of normal liver enzymes in patients with chronic hepatitis C may be related to host factors particularly immunologic, where possible equilibrium between HCV replication and host immune response results in weak or no cell mediated response directed to HCV infected cells [20] . In the present study there were high statistical significant differences between the three studied groups as regard . Both decreased Albumin and the Albumin/Globulin (A/G) levels were indicators of serious liver damage [22] . In the present study there was statistical significant increase in viral load by PCR in Group III compared to Group II (MW=2.38 , p value<0.05). Determination of HCV RNA levels has become an essential part of patient care, from early diagnosis of infection to treatment monitoring [23] . . The same findings were observed by Niu et al., who demonstrated a positive association between CHC and plasma IL-18 levels [25] . In the present study there was positive high relation between degree of liver fibrosis and serum level of IL-18 in HCV patients (K=19.9, P value <0.001). It is possible that up-regulation of IL-18 production has a role in the development of chronicity and accelerates the evolution of chronic hepatitis towards cirrhosis [26] . In accordance with these results, Said et al., observed positive correlation between IL-18 serum level both METAVIR necroinflammatory grade and fibrosis stage [27] . The present study showed no correlation between IL-18 and age, ALT, T.Bilirubin, D.Bilirubin, Albumin, Prothrombin Time, Concentration, INR. However, there was nonsignificant positive correlation between serum IL-18 and AST in group II ( r =0.06, P value =0.76) while there was significant positive correlation between serum IL-18 and AST in group III ( r=0.32, P value =0.03). This is in agreement with some authors who suggested that serum aminotransferases, especially the AST level, were associated with liver damage explaining more release of AST from liver cell injury in group Ш [28] . In the present study there was positive high significant correlation between IL-18 level and viral load in Group III (r=0.55, p value<0.01). Patients treated with PEG-IFN and ribavirin showed high relation between serum IL-18 level and HCV-RNA titers [29] . CONCLUSION This study revealed that Serum IL-18 is significantly increase in chronic HCV patients and is correlated with liver fibrosis staging determined by fibroscan. So, IL-18 can be used as non-invasive pro inflammatory marker for detection of the chronicity and severity of liver fibrosis in chronic hepatitis c patients. Further studies are needed on large number of subjects to investigate IL-18 response to infection with various genotypes of HCV (specifically genotype 4). Follow up of patients is recommended to detect the association between serum IL-18 levels and response to different treatment modalities.
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